Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


EU rules close research and development/generic gap

Research-based and generic pesticide companies are becoming less distinct as they face similar regulatory requirements under the EU agrochemical registration Directive (91/414). Terry Tooby, regulatory affairs director at UK consultancy JSC International, observed the trend at the AgChem Forum conference in September in Berlin, Germany. Most applications for EU approval of off-patent products now come from generic companies, Mr Tooby said. "With mergers and acquisitions, industry structure has changed dramatically," Mr Tooby pointed out. Such changes and the need to meet strict registration requirements means that the distinction between generics and R&D companies is becoming less well defined, he said.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts